Investor Relations Home

There are no items to display.

Stock Quote

MASI (Common Stock)
Exchange
Price
Change (%)
Volume
Data as of Copyright Nasdaq. Minimum 15 minutes delayed.

Online Investor Kit

	Masimo Reports Second Quarter 2017 Financial Results
	2016 Annual Report
	2016 Form 10K
	2017 Proxy Statement
	2017 Proxy Statement Supplement No.1
	2017 Proxy Statement Supplement No. 2

Corporate Profile

We are a global medical technology company that develops, manufactures, and markets a variety of noninvasive monitoring technologies. Our mission is to improve patient outcomes and reduce the cost of care by taking noninvasive monitoring to new sites and applications. We were incorporated in California in May 1989 and reincorporated in Delaware in May 1996.

Our core business is measure through motion and low perfusion arterial blood oxygen saturation and pulse rate monitoring, kno... More >>

Upcoming Events

There are currently no events to display.

Recent News

RSS Feeds | More >>

02/06/09

Summary Toggle New Clinical Study Presented at the Society for Critical Care Medicine Shows Value of Pulse CO-Oximetry(TM) to Identify Acquired Methemoglobinemia 1 out of 7 HIV+ Patients Receiving Dapsone Therapy at Significant Health Risk Due to Dangerously High Levels of Methemoglobin IRVINE, Calif ., Feb.
02/05/09

Summary Toggle Masimo to Report Fourth Quarter and Fiscal Year 2008 Financial Results on March 3, 2009 IRVINE, Calif., Feb 05, 2009 /PRNewswire-FirstCall via COMTEX/ -- Conference call and webcast to begin after markets close at 2:00 p.m. PT (5:00 p.m.
02/03/09

Summary Toggle Masimo Files Patent Infringement Suit Against Philips IRVINE, Calif ., Feb.
01/30/09

Summary Toggle New Multi-Center Study Finds Masimo SET Pulse Oximetry Screening Significantly Improves Detection of Congenital Heart Disease in Newborns Study Published in British Medical Journal Indicates Masimo SET May Also Reduce the Need for Pre-Operative Neonatal Intensive Care and Prevent Long-term Neurological Morbidity IRVINE, Calif ., Jan.
01/20/09

Summary Toggle Clinicians at Dartmouth-Hitchcock Medical Center Present New Data Showing Masimo Rainbow SET(R) Oximetry and Patient SafetyNet(TM) Improves Patient Outcomes and Reduces the Cost of Care Presentation at the Society for Technology in Anesthesia Annual Meeting Quantifies Decreases in Rescue Calls and ICU Transfers with Improved ICU Utilization IRVINE, Calif ., Jan.
12/23/08

Summary Toggle Masimo Rainbow SET(R) SpCO(R) and SpMet(R) Measurements Receive CPT Codes and Medicare Reimbursement IRVINE, Calif ., Dec.
12/23/08

Summary Toggle Masimo to Present at the 27th Annual J.P. Morgan Healthcare Conference IRVINE, Calif ., Dec. 23 /PRNewswire-FirstCall/ -- Masimo Corporation (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion pulse oximetry, today announced that its management is scheduled to present at the 27th Annual J.P.
12/16/08

Summary Toggle AARC Presentation Cites Masimo Patient SafetyNet as Key Factor in 'Improving Patient Outcomes and Reducing Costs' in Post-Acute Care Facilities Masimo also receives the AARC Zenith Award for Equipment and Service Excellence at the 54th Annual International Respiratory Congress in Anaheim IRVINE, Calif ., Dec.
11/18/08

Summary Toggle Nihon Kohden Expands Integration of Masimo SET(R) Pulse Oximetry Technology Worldwide Agreement with Japan's leading medical equipment provider broadens availability of Masimo SET to the global clinical community IRVINE, Calif., Nov.
11/06/08

Summary Toggle Masimo to Present at Lazard Capital Markets 5th Annual Healthcare Conference IRVINE, Calif., Nov.

Receive E-mail Alerts

Sign up here to receive e-mail alerts whenever Masimo Corporation posts new information to the site.

To request a copy of the Annual Report, click here .